Kraig Biocraft Laboratories (KBLB) Operating Leases (2019 - 2025)

Kraig Biocraft Laboratories has disclosed Operating Leases across 7 years of filings, most recently posting $171162.0 for Q4 2025.

• Operating Leases for Q4 2025 came in at $171162.0, up 95.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $171162.0 (up 95.67% YoY), and the FY2025 annual result was $171162.0, up 95.67% from the prior year.
• Operating Leases came in at $171162.0 for Q4 2025 at Kraig Biocraft Laboratories, down from $184030.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $239237.0 in Q1 2021 to a low of $8454.0 in Q1 2023.
• The 5-year median for Operating Leases is $58944.0 (2021), against an average of $84241.2.
• Across the five-year window, Operating Leases plunged 82.26% in 2023 and jumped 585.96% in 2024, its largest moves.
• Kraig Biocraft Laboratories' Operating Leases stood at $59897.0 in 2021, then sank by 65.45% to $20697.0 in 2022, then jumped by 162.69% to $54368.0 in 2023, then soared by 60.89% to $87474.0 in 2024, then jumped by 95.67% to $171162.0 in 2025.
• The last three Operating Leases figures came in at $171162.0 (Q4 2025), $184030.0 (Q3 2025), and $34498.0 (Q2 2025), per Business Quant data.